Pfizer <a href="https://www.reuters.com/markets/companies/PFE.N" target="_blank">(PFE.N)</a> on Tuesday urged investors to focus on growth in non-COVID products such as the new RSV vaccine Abrysvo as slumping demand for COVID-19 vaccines and treatments pushed…